fiercepharmaSeptember 29, 2017
Call it unintended-but-predictable consequences: Launched this summer, a pharma industry campaign called "Let's Talk About Cost" highlights the role of insurers and middlemen in drug spending. Now, top insurers are talking back, with no punches pulled.
America's Health Insurance Plans, the insurance industry's lobby group, called out pharma on Twitter in a series of posts about drug expenses, misuse of drug laws, price hikes, patent deals and more. It isn't the first time the industries have sparred and won't be the last.
Contact Us
Tel: (+86) 400 610 1188
WhatsApp/Telegram/Wechat: +86 13621645194
Follow Us: